Aug. 26, 2008 — Cymbalta, a prescription sedate used to treat depression, generalized anxiety disorder, diabetic nerve torment, and fibromyalgia, may ease chronic low back pain.
That’s according to a study displayed in Madrid at the 12th congress of the European League of the Neurological Sciences.
The consider included 236 grown-ups with inveterate low back pain who weren’t discouraged. They took Cymbalta or a fake treatment medicate every day for 13 weeks.
Average week by week pain scores, measured some time recently taking Cymbalta or the fake treatment and again at the conclusion of the think about, showed more noteworthy advancement within the Cymbalta group.
But that wasn’t true in a moment study, moreover presented in Madrid. In that study, there weren’t any significant differences in before-and-after normal week by week pain evaluations among adults with chronic low back pain who took Cymbalta or a fake treatment once daily for 13 weeks. Cymbalta trumped the fake treatment from the third to the eleventh weeks, but not for the entire study overall.
Why did those comes about vary within the two studies? That’s not clear. But the considers did differ slightly in their doses.
The think about in which Cymbalta bested the fake treatment for average weekly torment scores used a 60 milligram dosage of Cymbalta, a 120 milligram measurements, or a placebo. The ponder in which Cymbalta didn’t beat the fake treatment too included a lower (20 milligram) dose of Cymbalta, as well as the 60 milligram dosage, 120 milligram measurements, and placebo.
In both ponders, side impacts more commonly detailed by patients taking Cymbalta included nausea, dry mouth, weariness, the runs, intemperate sweating (hyperhidrosis), discombobulation, and stoppage. That’s in line with past inquire about on Cymbalta.
Both ponders were funded by Eli Lilly and Company, the drug company that creates Cymbalta.